Publications in collaboration with researchers from Hospital Virgen del Camino (14)

2023

  1. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype

    Journal of Pathology, Vol. 259, Núm. 1, pp. 103-114

2019

  1. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

2017

  1. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)

    Oral Oncology, Vol. 70, pp. 58-64

2016

  1. Prognostic factors of recurrence and survival in vulvar melanoma

    International Journal of Gynecological Cancer, Vol. 26, Núm. 7, pp. 1307-1312

  2. Recomendaciones CODEPEH 2014 para la detección precoz de la hipoacusia diferida

    Anales de Pediatria, Vol. 85, Núm. 4, pp. 215.e1-215.e6

2015

  1. Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

    European Urology, Vol. 68, Núm. 2, pp. 256-262

  2. Resultados oncológicos según el tipo de resección en el tratamiento del cáncer de recto

    Cirugia Espanola, Vol. 93, Núm. 4, pp. 229-235

  3. Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial

    European Urology, Vol. 67, Núm. 3, pp. 508-516

2014

  1. Multicenter study of outcome in relation to the type of resection in rectal cancer

    Diseases of the Colon and Rectum, Vol. 57, Núm. 7, pp. 811-822

2011

  1. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: External validation of the EORTC risk tables

    European Urology, Vol. 60, Núm. 3, pp. 423-430

2010

  1. Minimally invasive lateral approach in total hip replacement: A prospective randomized study

    Revista Espanola de Cirugia Ortopedica y Traumatologia, Vol. 54, Núm. 1, pp. 27-33

  2. Minimally invasive subvastus approach: Improving the results of total knee arthroplasty: A prospective, randomized trial

    Clinical Orthopaedics and Related Research

2009

  1. Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

    Journal of Urology, Vol. 182, Núm. 5, pp. 2195-2203

2008

  1. Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

    European Urology, Vol. 53, Núm. 5, pp. 992-1002